Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,202Revenue (TTM) $M124Net Margin (%)-128.6Altman Z-Score2.6
Enterprise Value $M6,073EPS (TTM) $-0.7Operating Margin %-79.6Piotroski F-Score6
P/E(ttm)--Beneish M-Score3.7Pre-tax Margin (%)-128.5Higher ROA y-yY
Price/Book19310-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsY
Price/Sales42.05-y EBITDA Growth Rate %--Current Ratio2.1Lower Leverage y-yY
Price/Free Cash Flow59.5y-y EBITDA Growth Rate %--ROA % (ttm)-36.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M286ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with EXEL

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

EXEL is held by these investors:

EXEL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lamb PeterEVP, Scientific Strategy & CSO 2017-02-01Sell70,000$18.6515.98view
Lamb PeterEVP, Scientific Strategy & CSO 2017-01-03Sell70,000$14.6547.65view
FELDBAUM CARL BDirector 2016-12-16Sell25,000$17.0327.01view
Garber Alan MDirector 2016-12-09Sell7,832$16.927.99view
SCANGOS GEORGE ADirector 2016-12-07Sell204,894$17.8121.45view
Lamb PeterEVP, Scientific Strategy & CSO 2016-12-01Sell70,000$16.6629.83view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-12-01Sell22,000$16.7329.29view
MORRISSEY MICHAELPresident and CEO 2016-11-09Sell200,000$1544.2view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-11-09Sell22,000$1544.2view
Lamb PeterEVP, Scientific Strategy & CSO 2016-11-09Sell70,000$13.1564.49view

Quarterly/Annual Reports about EXEL:

News about EXEL:

Articles On GuruFocus.com
Top Performing Contest Portfolios from 2016 Jan 17 2017 
7 Stocks Outperforming the Market Jan 12 2017 
Why You Should Be Using the Altman Z-Score Dec 18 2016 
The Best-Performing Non-S&P Stocks of 2015 Dec 30 2015 
5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. Sep 28 2014 
Weekly 3-Year Low Highlights: UAN, CLD, EXEL, QNST Sep 06 2014 
Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian Trust, Millennial Media Inc., Exelix May 05 2014 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Exelixis Inc. Reports Operating Results (10-K) Feb 22 2011 

More From Other Websites
TriMas (TRS) to Post Q4 Earnings: What's in the Cards? Feb 23 2017
Exelixis (EXEL) Q4 Earnings: Is Positive Surprise in Store? Feb 22 2017
Patterson Companies (PDCO) Q3 Earnings: What's in Store? Feb 21 2017
Forget Alexion, Buy these 4 Biotech Stocks Instead Feb 20 2017
Medtronic (MDT) Q3 Earnings: Disappointment in the Cards? Feb 20 2017
Exelixis Announces Phase 1 Trial Results for Cabozantinib in Combination with Nivolumab with or... Feb 17 2017
Radius Health (RDUS) Q4 Earnings: Will the Stock Disappoint? Feb 17 2017
Easier Regulatory Environment Could Send Biotech Industry Skyrocketing in 2017: Today's Reports on... Feb 17 2017
The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics, Exelixis and Akebia... Feb 14 2017
Forget Gilead, Buy These 5 Biotech Stocks Instead Feb 13 2017
Zacks.com featured highlights: Exelixis, RPC, Unit and Fortress Transportation and Infrastructure... Feb 10 2017
Exelixis (EXEL) Shares March Higher, Can It Continue? Feb 10 2017
Harry Boxer’s stocks to watch: biotechnology and technology Feb 09 2017
Buy 4 Stocks Riding High on Superb Earnings Acceleration Feb 09 2017
5 Drug Stocks Poised to Beat Earnings Estimates in Q4 Feb 09 2017
Four Biotech Stocks Breaking Out Feb 08 2017
The Zacks Analyst Blog Highlights: Celgene, Exelixis, Ligand Pharmaceuticals and RedHill Biopharma Feb 08 2017
The Zacks Analyst Blog Highlights: Celgene, Cellectis S.A., Exelixis, Exact Sciences and Sunesis... Feb 08 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)